FDA warns against young-blood transfusions for aging, Alzheimer's

FDA warns against young-blood transfusions for aging, Alzheimer's

FDA: Young-blood transfusions provide ‘no proven clinical benefit’ for aging, Alzheimer’s

By REBECCA ROBBINS

ADOBE

The plasma infusions provide “no proven clinical benefit” against normal aging, Alzheimer’s disease, or a host of other diseases, the agency says.

READ MORE